These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 9275659)
1. [Studies on MDM2 oncogene expression and its effect on pancreatic carcinoma cells]. Guo H; Liu T; Gao J Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):232-5. PubMed ID: 9275659 [TBL] [Abstract][Full Text] [Related]
2. Inhibiting effect of murine double minute-2 oncogene on apoptosis induced by retroviral-mediated wild-type p53. Guo H; Liu T; Gao J Chin Med J (Engl); 1998 Dec; 111(12):1102-6. PubMed ID: 11263374 [TBL] [Abstract][Full Text] [Related]
3. [Murine Doube Minute 2 oncogene inhibited apoptosis induced by retroviral-mediated wild-type p53]. Guo H; Liu T; Gao J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Dec; 20(6):401-6. PubMed ID: 11717930 [TBL] [Abstract][Full Text] [Related]
4. Interaction between gene p53 and oncogene mdm2 in human glandular lung cancer cell line GLC-82. Li P; Rao G; Chen Y; Ding Z; Yu W Chin Med J (Engl); 1999 Sep; 112(9):850-3. PubMed ID: 11717960 [TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
6. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer. Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472 [TBL] [Abstract][Full Text] [Related]
7. [The effect of adenovirus-mediated wild-type p53 expression on the growth of human pancreatic carcinoma cell line cells]. Guo H; Liu T; Gao J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Oct; 20(5):345-50. PubMed ID: 11717990 [TBL] [Abstract][Full Text] [Related]
8. Selective compartmentalization of different mdm2 proteins within the nucleus. Maxwell SA Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679 [TBL] [Abstract][Full Text] [Related]
9. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression. Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270 [TBL] [Abstract][Full Text] [Related]
10. MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells. Urashima M; Teoh G; Chauhan D; Ogata A; Shirahama S; Kaihara C; Matsuzaki M; Matsushima H; Akiyama M; Yuza Y; Maekawa K; Anderson KC Blood; 1998 Aug; 92(3):959-67. PubMed ID: 9680365 [TBL] [Abstract][Full Text] [Related]
11. Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53. Knippschild U; Kolzau T; Deppert W Oncogene; 1995 Aug; 11(4):683-90. PubMed ID: 7651732 [TBL] [Abstract][Full Text] [Related]
12. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Landers JE; Cassel SL; George DL Cancer Res; 1997 Aug; 57(16):3562-8. PubMed ID: 9270029 [TBL] [Abstract][Full Text] [Related]
13. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365 [TBL] [Abstract][Full Text] [Related]
14. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells. Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991 [TBL] [Abstract][Full Text] [Related]
15. [Detection of p53 and MDM2 gene expression in osteosarcoma with biotin-labelled in situ]. Wang X; Wang S; Feng C Zhonghua Wai Ke Za Zhi; 1997 Mar; 35(3):178-80. PubMed ID: 10374529 [TBL] [Abstract][Full Text] [Related]
16. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer. Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Gudas JM; Nguyen H; Klein RC; Katayose D; Seth P; Cowan KH Clin Cancer Res; 1995 Jan; 1(1):71-80. PubMed ID: 9815889 [TBL] [Abstract][Full Text] [Related]
18. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer. Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335 [TBL] [Abstract][Full Text] [Related]
19. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells. Capoulade C; Bressac-de Paillerets B; Lefrère I; Ronsin M; Feunteun J; Tursz T; Wiels J Oncogene; 1998 Mar; 16(12):1603-10. PubMed ID: 9569028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]